After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists…. read more.
Targeting a condition suffered by nearly a billion people worldwide, a new study from Flinders University has shown a drug previously used to treat depression can reduce obstructive… read more.
Mandates designed to decrease opioid prescriptions in the U.S. have worked, but they also have had an unintended and undesirable public health outcome, according to a recent study… read more.
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in… read more.
The European Medicines Agency (EMA) has backed a joint statement by global regulators calling for greater collaboration on the use of real-world evidence in regulatory decision-making. The potential… read more.
Researchers at the University of Liverpool have identified an increasing trend in medicine-related harm leading to hospital admission. The trend is connected to a rising tide of multiple… read more.
Researchers at University of Limerick in Ireland have developed a new modelling approach to pharmaceutical manufacturing that could reduce the time required to bring v. Professor Gavin Walker… read more.
Leicester researchers are working with NHS partners in the East of England to lead the way in delivering the NHS’ goal of halving the amount of opioids prescribed… read more.
In a questionnaire-based study published in Pharmacology Research & Perspectives that included 485 fully trained nurses of 107 home care services, nearly half of all nursing staff made at least… read more.
Microfluidic devices are compact testing tools made up of tiny channels carved on a chip, which allow biomedical researchers to test the properties of liquids, particles and cells… read more.
Ketamine is effective for the acute treatment of severe suicidal ideation, researchers reported on February 2, 2022 in The BMJ/British Medical Journal. “This study confirmed in a large… read more.
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
